Skip to main content

Advertisement

SpringerLink
Log in

Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation

  • Brief Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Mutations in BRCA1 and BRCA2 genes confer a high risk of breast and ovarian cancer but the incomplete penetrance of these mutations suggests that other genetic and/or environmental factors may modify this risk. We present a family where all affected members carried a mutation in the BRCA1 gene and the index case had suffered from cancer twice in the last 27 years, whereas her monozygotic twin sister, also a carrier of the mutation, remained healthy. As copy number variants (CNVs) contribute to phenotypic diversity, a comparative genomic hybridization array (CGH) was performed to see whether the differences in the CNV profile were a modifier factor of the phenotype in our monozygotic twins. Our results show that differences in the CNVs profile were not the cause of the extremely variable penetrance observed in our MZ twin. The search for an explanation should not therefore be limited to genetic changes at the level of the DNA sequence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Collaborative Group in Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399

    Article  Google Scholar 

  2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71

    Article  CAS  PubMed  Google Scholar 

  3. Wooster R, Bignell G, Lancaster J, Swift S, Seal S et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792

    Article  CAS  PubMed  Google Scholar 

  4. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130

    Article  CAS  PubMed  Google Scholar 

  5. Begg CB, Haile RW, Borg A, Malone KE, Concannon P et al (2008) Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299(2):194–201

    Article  CAS  PubMed  Google Scholar 

  6. Milne RL, Osorio A, Cajal TR, Vega A, Llort G et al (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14(9):2861–2869

    Article  CAS  PubMed  Google Scholar 

  7. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM et al (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45(7):646–655

    Article  CAS  PubMed  Google Scholar 

  8. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31(1):33–36

    Article  CAS  PubMed  Google Scholar 

  9. Rahman N, Seal S, Thompson D, Kelly P, Renwick A et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165–167

    Article  CAS  PubMed  Google Scholar 

  10. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T et al (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875

    Article  CAS  PubMed  Google Scholar 

  11. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55–59

    Article  CAS  PubMed  Google Scholar 

  12. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7):870–874

    Article  CAS  PubMed  Google Scholar 

  13. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1093

    Article  CAS  PubMed  Google Scholar 

  14. Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98(8):535–544

    Article  PubMed  Google Scholar 

  15. Mitchell G, Antoniou AC, Warren R, Peock S, Brown J (2006) Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 66(3):1866–1872

    Article  CAS  PubMed  Google Scholar 

  16. Milne RL, Osorio A, Ramón y Cajal T, Baiget M, Lasa A et al (2010) Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 119(1):221–232

    Article  CAS  PubMed  Google Scholar 

  17. Diez O, Brunet J, Sanz J, del Rio E, Alonso MC, Baiget M (1997) Differences in phenotypic expression of a new BRCA1 mutation in identical twins. Lancet 350(9079):713

    Google Scholar 

  18. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK et al (2004) Detection of large-scale variation in the human genome. Nat Genet 36(9):949–951

    Article  CAS  PubMed  Google Scholar 

  19. Itsara A, Cooper GM, Baker C, Girirajan S, Li J et al (2009) Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 84(2):148–161

    Article  CAS  PubMed  Google Scholar 

  20. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH et al (2006) Global variation in copy number in the human genome. Nature 444(7118):444–454

    Article  CAS  PubMed  Google Scholar 

  21. Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S et al (2008) Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 82(3):763–771

    Article  CAS  PubMed  Google Scholar 

  22. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215

    Article  CAS  PubMed  Google Scholar 

  23. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J et al (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–84

    Article  CAS  PubMed  Google Scholar 

  24. Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898–5905

    Article  CAS  PubMed  Google Scholar 

  25. Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout WM et al (2001) Epigenetic instability in ES cells and cloned mice. Science 293:95–97

    Article  CAS  PubMed  Google Scholar 

  26. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F et al (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102(30):10604–10609

    Article  CAS  PubMed  Google Scholar 

  27. Singh SM, Murphy B, O’Reilly R (2002) Monozygotic twins with chromosome 22q11 deletion and discordant phenotypes: updates with an epigenetic hypothesis. J Med Genet 39(11):e71

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genetics Department, Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain

    A. Lasa, M. Cornet & M. Baiget

  2. Clinical Oncology Department, Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain

    T. Ramón y Cajal, C. Alonso & A. Barnadas

  3. Clinical Oncology Department, Corporació Parc Taulí, Sabadell, Barcelona, Spain

    G. Llort

  4. NIMGenetics, Madrid, Spain

    J. Suela & J. C. Cigudosa

  5. U-705 CIBERER, Barcelona, Spain

    M. Cornet & M. Baiget

  6. Servicio de Genética, Hospital de la Santa Creu i Sant Pau, Avda. Padre Claret, 167, 08025, Barcelona, Spain

    M. Baiget

Authors
  1. A. Lasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Ramón y Cajal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Llort
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Suela
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. C. Cigudosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Cornet
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Alonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Barnadas
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Baiget
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Baiget.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lasa, A., Ramón y Cajal, T., Llort, G. et al. Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation. Breast Cancer Res Treat 123, 901–905 (2010). https://doi.org/10.1007/s10549-010-0877-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0877-0

Keywords

Search

Navigation